Apyvax Confirms No Rush to Sell Company, Awaits Trial Results
The CEO of Apyvax stated that the company is not in a hurry to sell itself, planning to raise funds after releasing critical trial data in June. This comes amid strong rumors of a potential acquisition by major pharmaceutical companies.